HYZYD Drug Patent Profile
✉ Email this page to a colleague
When do Hyzyd patents expire, and when can generic versions of Hyzyd launch?
Hyzyd is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.
The generic ingredient in HYZYD is isoniazid. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hyzyd
A generic version of HYZYD was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
Summary for HYZYD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 154 |
Patent Applications: | 4,299 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYZYD at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HYZYD
US Patents and Regulatory Information for HYZYD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medpointe Pharm Hlc | HYZYD | isoniazid | TABLET;ORAL | 080134-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Medpointe Pharm Hlc | HYZYD | isoniazid | TABLET;ORAL | 080134-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |